Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Size: px
Start display at page:

Download "Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016"

Transcription

1 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: A Swell Talk on Edema Laura Novak, MD Speaker has no disclosures and there are no conflicts of interest. The speaker has attested that their presentation will be free of all commercial bias toward a specific company and its products. The speaker indicated that the content of the presentation will not include discussion of unapproved or investigational uses of products or devices.

2 Water, Water Everywhere L Novak Disclosure The speaker has no conflict of interest, financial agreement, or working affiliation with any group or organization. 2 Objectives Be able to describe and assess peripheral edema Be familiar with appropriate diagnostic testing Discuss effective management based on the etiology of edema I have no conflicts of interest to report 3 1

3 30 minutes to cover edema Dozens of causes Dozens of treatments So we aren t going to cover everything but will focus on the more common causes (no picnic) 4 We ll start with the basics Fluid circulation 2 systems Vascular Lymphatic 5 There s a lot going on in there 6 2

4 Regulated by : Fluid Volume Absorption in the gut Excretion by the kidney Antidiuretic hormone Multiple ion pumps 7 Fluid Balance Fluid is filtered out into tissue by Arterial pressure Intravascular volume Fluid is drawn back into circulation by Protein concentration in blood Local tissue pressure Microscopic pores 8 Disruption of Fluid Balance Increased circulating volume Back pressure from obstruction Decreased protein concentration Inflammation and leaking 9 3

5 Edema Palpable fluid in the periphery Clinically apparent at 2 L (Circulating volume is ~ 5 L) 10 Etiologies can overlap A morbidly obese patient may have Diastolic CHF ( HFpEF ) Pulmonary HT Sleep apnea AND Venous insufficiency BUT: 11 We will discuss them as separate entities 12 4

6 The first questions to ask Bilateral or unilateral Generalized or localized Normal or increased circulatory volume Bilateral and generalized edema Common systemic causes: Cardiac Right sided HF Pulmonary HT Renal disease Cirrhosis 15 5

7 Cardiac Failure Perceived decreased cardiac output The body retains fluid to correct the deficit Left sided HF pulmonary edema Right sided HF peripheral edema Can have both types 16 Right-sided failure Increased pulmonary artery pressure Increased jugular venous distention Peripheral edema 17 Jugular venous distention An indirect measure of right heart pressure Exam has limits, but is helpful when high 18 6

8 Lay the patient at a 45 degree angle. Turn their head away from you. Look for a > 3 cm column of venous blood (external jugular) 19 Confirmatory CHF Testing Echocardiogram Distinguishes systolic(hfref) / diastolic (HFpEF) Can find pulmonary hypertension BNP (b-type natiuretic peptide) Marker of ventricular stretch Most helpful in inpatient settings Elevated in renal failure (so don t use) 20 Treatment for CHF Salt restriction, medications, risk factor reduction but: We will discuss diuresis Goal is to: Decrease excess intravascular volume Which draws edema in from periphery BUT must maintain cardiac output Warm and dry 21 7

9 Good News! 22 Loop Diuretics Loop diuretics are the strongest diuretics Three common loop diuretics All are equally effective at equipotent doses Furosemide (Lasix) - 40 mg po ($ 4) Bumetanide (Bumex) - 1 mg po ($20) Torsemide (Demadex) - 20 mg po ($35) (In most situations,change dose before brand) 23 Dosing Minimal effective dose Found by therapeutic trial Like a light switch If a given dose is not effective, using it bid will not increase efficacy 24 8

10 All can be given IV Dosing Furosemide IV is unique more potent than po 20 mg IV = 40 mg po The others are not 25 Side effects Low potassium and Mg Hypotension Increased BUN / Cr Patients avoid taking loops due to frequency / incontinence 26 Thiazides Weak diuretics Not used for diuresis, BUT Can be used in combination with loops in resistant edema Blocks reabsorption of salt and water further down the nephron 27 9

11 Any thiazide* Co-administration Give at the same time (or 30 min earlier) 2x diuresis but significant potassium loss Use sparingly (and stop HCTZ for HTN when the pt starts a loop) (* eg HCTZ, Chlorthalidone, metolazone (Zaroxolyn)) 28 Potassium sparing diuretics Spironolactone Weak diuretic Used in CHF but not for diuresis Renin-angiotensin system 29 Diuresis in CHF Daily or bid loop at an effective level Try to achieve a dry weight Obtain daily weights. Call if weight increases by ~ 3 pounds Ask what tipped the patient out of balance Increase diuretic short term 30 10

12 Edema in renal disease Fluid overload from Renal failure Nephrotic syndrome (severe protein loss) As there is intravascular fluid overload, diuresis can be tried until disease specific treatments begin 31 Cirrhosis There are many causes for cirrhotic liver failure Appropriate circulating volume with third spacing Diuresis needs to be cautious spironolactone +/- furosemide 100mg/40mg ratio 32 For most patients, Bilateral generalized edema should be treated with diuresis and treatment of the underlying disease 33 11

13 There are other, less obvious causes of generalized edema 34 Idiopathic edema Obstructive sleep apnea (OSA) Frequent cause of idiopathic edema Edema can be seen with or without pulmonary HT CPAP may reverse edema 35 Dieting Use of diuretics for weight loss or water retention Sets up a cycle of use - rebound - use Don t prescribe / Wean 36 12

14 Medications The timing is the clue Vasodilators Nifedipine (Procardia) Amlodipine (Norvasc) Glitazones pioglitazone (Actos) rosiglitazone (Avandia) NSAIDs Treatment- a trial off meds 37 Change in direction 38 Localized edema - bilateral Chronic venous stasis Gradual accumulation of fluid in the legs from back pressure and venous reflux Over time the legs develop pitting, hemosiderin deposits, eczematous changes, deformity, scarring and ulceration The chronic redness can mimic cellulitis 39 13

15 Pitting Management There is no generalized fluid overload Intravascular volume is normal Try to avoid diuretics Elevation Feet above heart for 30 minutes twice a day So not a recliner Not MOST recliners 42 14

16 Compression hose Graduated compression mm Hg for most (moderate) mm Hg if severe (firm-extra firm) (Ted hose 8-10) 43 Compression Hose OTC ($20) or Rx ( $$) Knee high Open or closed toe Small, med, large Can custom-size ($$$) Eg Jobst Can get OTC on Amazon What can t you get on Amazon? 44 Hard to put on Zippers ($70) Stocking applicators ($25) Again, Amazon Have an expert in your office 45 15

17 Compression Stockings Don t use in Peripheral Vascular Disease screen with ABI if at risk 46 Exercise In one study, 1/3 of patients with chronic venous stasis didn t have one 10 min walk per week Chair exercise Circling and flexing feet 47 Horse chestnut The active ingredients have been found to decrease edema and pain in several small studies BUT: They are coumarin derivatives and can t be given with warfarin They interact with most diabetes drugs and antiplatelet meds 48 16

18 Venous ablation 49 Emollients Skin care Vaseline, Aquaphor Hydrocortisone cream if there are eczematous changes If ulceration develops Intensify treatment Consider a wound care clinic 50 Diuretics When edema becomes severe enough, we usually add diuretics But don t stop promoting the mechanical treatments 51 17

19 Lymphedema Disrupted lymph system Obesity vs obstruction vs trauma Hard to distinguish from venous stasis In early stages, it pits and swells. With time, the skin thickens and there is more rigidity and less pitting The skin near the toes won t tent (Stemmer s sign) Stemmer s sign 54 18

20 Treatment Diuretics don t mobilize lymph spaces Treatment : 2-4 weeks of: Compression wraps Decongestive massage Pumping Followed by compression stockings Low compliance High rebound Lipedema Fat deposits Spares ankles and feet 57 19

21 58 Unilateral edema DVT (deep vein thrombosis) Baker s cyst (popliteal synovial cyst) Obstruction 59 DVT/ VTE Thrombus in the deep venous system Risks trauma, immobilization, travel, cancer, hormones Exam: Unilateral swelling, pain, warmth Homan s sign (pain with dorsiflexion of foot) is not helpful if positive or negative 60 20

22 Diagnosis In low probability patients, use a risk assessment tool (there are many) and a d-dimer blood test In higher probability patients, use ultrasound 61 Well s Risk Assessment 62 D-dimer Thrombin breakdown product Useful if negative, not helpful if positive Don t order in post-op patients Use age adjusted normals If risk assessment tool is low and d-dimer is negative, you don t need an ultrasound Risk scales miss some patients. When in doubt, image the patient 63 21

23 Duplex scanning Two tests: Ultrasound for compressibility Color doppler for flow Limited by: Obesity Hard to distinguish new clot from old clot 64 Ultrasound - compressibility 65 Color doppler flow 66 22

24 Treatment Choice Chest Supplement 2016 recommends : Start with an oral Xa inhibitor Apixaban and rivaroxaban don t need bridged Dabigatrin and edoxaban need LMWH first Outpatient treatment when possible Compression stockings are no longer recommended unless there s symptomatic postthrombotic syndrome 67 Orals Rivaroxiban (Xarelto) Apixaban (Eliquis) Eboxaban (Savaysa) Dabigatran (Pradaxa) $300/month Vs hospital stay or INRs No reversibility at this time 68 Length of treatment Provoked? -3 mo Unprovoked? 3 mo then risk assess Recurrent no end point Cancer - LMWH 3 mo then reassess 69 23

25 Reassess Risk of bleeding (3-5%) vs risk of recurrence (up to 20 % for unprovoked clots) More data D dimer off meds or repeat duplex Risk scales (HERDOO) Aspirin post anticoagulation if unprovoked 70 Baker s cyst Synovial bursal cyst Best seen with a straight leg Best felt with a bent leg Can confirm with Ultrasound if needed Treatment Observation Drainage +/- steroids High recurrence rate 71 Baker s cyst 72 24

26 Edema from Obstruction External compression of the vein by nodes, tumor, constriction Look for the source 73 Summary Systemic,generalized edema should be treated by addressing the disease process and appropriate diuresis Chronic venous stasis and lymphedema should be treated with compression before diuretics In real life, many diseases overlap

When is Limb Edema Not Heart Failure

When is Limb Edema Not Heart Failure When is Limb Edema Not Heart Failure An Approach to the Swollen Leg Greg Harding M.D. Vascular Surgeon Faculty/Presenter Disclosure Faculty: Greg Harding M.D. Relationships with commercial interests: None

More information

Venous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.

Venous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI. Venous Insufficiency Ulcers Patient Assessment: Superficial varicosities Evidence of healed ulcers Dermatitis Normal ABI Edema Eczematous skin changes 1. Scaling 2. Pruritus 3. Erythema 4. Vesicles Lipodermatosclerosis

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT) Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or

More information

With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis

With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis BRIGHAM AND WOMEN S HOSPITAL With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis Gregory Piazza, MD, MS Division of Cardiovascular Medicine Brigham and Women s Hospital April

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism Rajat Deo, MD, MTR Director of Translational Research in Cardiac Arrhythmias Division of Cardiovascular Medicine

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.

More information

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)

More information

DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.

DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D. DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE Jules B. Puschett, M.D. Diuretic Resistance A clinical circumstance in which patients do not respond to a combination of salt restriction and even large

More information

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital

More information

Misunderstandings of Venous thromboembolism prophylaxis

Misunderstandings of Venous thromboembolism prophylaxis Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario

More information

Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th,

Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th, Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th, 2015 Heart Failure (HF) Describe the natural course of

More information

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page

More information

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,

More information

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS

VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE

More information

CHAPTER 2 VENOUS THROMBOEMBOLISM

CHAPTER 2 VENOUS THROMBOEMBOLISM CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology

More information

Bumex vs lasix in hypoalbuminemia

Bumex vs lasix in hypoalbuminemia Bumex vs lasix in hypoalbuminemia What other foods in the diet cause edema?. The veins in the legs are responsible for transporting blood up to the veins of the torso, where it is then returned to the

More information

Therapeutics of Diuretics

Therapeutics of Diuretics (Last Updated: 08/22/2018) Created by: Socco, Samantha Therapeutics of Diuretics Thambi, M. (2017). The Clinical Use of Diuretics. Lecture presented at PHAR 503 Lecture in UIC College of Pharmacy, Chicago.

More information

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Slide 1. Slide 2. Slide 3. Outline of This Presentation Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous

More information

Rapid Fire-Top Articles You Need to Know

Rapid Fire-Top Articles You Need to Know Rapid Fire-Top Articles You Need to Know TRACY MINICHIELLO, MD CHIEF, ANTICOAGULATION& THROMBOSIS SERVICE- SAN FRANCISCO VAMC PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Financial Disclosures-NONE

More information

UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS

UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS UPDATE ON TREATMENT OF ACUTE VENOUS THROMBOSIS Armando Mansilha MD, PhD, FEBVS 16 th National Congress of the Italian Society of Vascular and Endovascular Surgery Bologna, 2017 Disclosure I have the following

More information

Approach to Thrombosis

Approach to Thrombosis Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation

More information

When is it lymphedema, when is it not lymphedema? UNDERSTANDING EDEMA. John Mulligan, RMT/CLT-LANA

When is it lymphedema, when is it not lymphedema? UNDERSTANDING EDEMA. John Mulligan, RMT/CLT-LANA When is it lymphedema, when is it not lymphedema? UNDERSTANDING EDEMA John Mulligan, RMT/CLT-LANA Learning Objectives How to identify stages of lymphedema The Gold Standard of Treatment for Lymphedema

More information

A VENOUS THROMBOEMBOLISM (VTE) TOWN HALL: Answering Your Top Questions on Treatment and Secondary Prevention

A VENOUS THROMBOEMBOLISM (VTE) TOWN HALL: Answering Your Top Questions on Treatment and Secondary Prevention A VENOUS THROMBOEMBOLISM (VTE) TOWN HALL: Answering Your Top Questions on Treatment and Secondary Prevention This handout is a supplemental resource to an educational video activity released on Medscape

More information

Venous Thromboembolic Disease Update

Venous Thromboembolic Disease Update Canadian Society of Internal Medicine Annual Meeting Calgary, Alberta, October 2014 Venous Thromboembolic Disease Update Benjamin Bell, MD FRCPC James Douketis, MD FRCPC On Behalf of Thrombosis Canada

More information

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely

More information

Patient Information. Preventing and treating blood clots

Patient Information. Preventing and treating blood clots Patient Information Preventing and treating blood clots 1_Clexane_Patient_Booklet_AW05.indd 1 8/04/2016 11:26 a The information provided in this document is for patients prescribed CLEXANE, and should

More information

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan Objectives Describe the prevalence of PE and DVT as it relates

More information

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.

Disclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach. Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,

More information

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT

UW MEDICINE PATIENT EDUCATION. Treating Blood Clots. What is a blood clot? DRAFT UW MEDICINE PATIENT EDUCATION Treating Blood Clots About deep vein thrombosis (DVT) and pulmonary embolism (PE) and how they are treated This handout explains blood clots, their symptoms, and how they

More information

Akash Ghai MD, FACC February 27, No Disclosures

Akash Ghai MD, FACC February 27, No Disclosures Akash Ghai MD, FACC February 27, 2015 No Disclosures Epidemiology Lifetime risk is > 20% for American s older than 40 years old. > 650,000 new cases diagnosed each year. Incidence increases with age: 2%

More information

Acute Versus Chronic DVT Imaging in the Vascular Lab Heather Gornik, MD, RVT, RPVI

Acute Versus Chronic DVT Imaging in the Vascular Lab Heather Gornik, MD, RVT, RPVI Acute Versus Chronic DVT Imaging in the Vascular Lab Heather Gornik, MD, RVT, RPVI Cleveland Clinic Heart and Vascular Institute Heather L. Gornik, MD has the following relationships to disclose: CVR Global

More information

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood

More information

How to prevent blood clots whilst in hospital and after your return home

How to prevent blood clots whilst in hospital and after your return home How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within

More information

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures Hemostasis PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures Disorders of Hemostasis - Hemophilia - von Willebrand Disease HEMOPHILIA A defect in the thrombin propagation phase

More information

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

Deep Vein Thrombosis and Pulmonary Embolism

Deep Vein Thrombosis and Pulmonary Embolism Page 1 of 12 PATIENT EDUCATION Deep Vein Thrombosis and Pulmonary Embolism Take Steps to Prevent DVTs and PEs Deep vein thrombosis and pulmonary embolism are serious conditions that can affect people of

More information

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the

More information

DOAC for VTE. Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University

DOAC for VTE. Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University DOAC for VTE Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University No disclosures Direct Oral Anticoagulants Understand VTE and the ACCP s position on it List the DOACs available in the US

More information

Inferior Vena Cava Filter for DVT

Inferior Vena Cava Filter for DVT Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If

More information

Pharmacotherapeutic Challenge Diuretic Resistance

Pharmacotherapeutic Challenge Diuretic Resistance Pharmacotherapeutic Challenge Diuretic Resistance Barry E. Bleske, Pharm. D, FCCP Associate Professor University of Michigan, College of Pharmacy Learning Objectives Describe the causes for HF readmission.

More information

New Anticoagulants Therapies

New Anticoagulants Therapies New Anticoagulants Therapies Rachel P. Rosovsky, MD, MPH October 22, 2015 Conflicts of Interest No disclosures 2 Agenda 3 Historical perspective Novel oral anticoagulants Stats Trials Approval Concerns/Limitations

More information

YOU will treat patients with heart MANAGING HEART FAILURE: 11/4/2014 ALL DIURETICS ARE NOT CREATED EQUAL. failure.

YOU will treat patients with heart MANAGING HEART FAILURE: 11/4/2014 ALL DIURETICS ARE NOT CREATED EQUAL. failure. MANAGING HEART FAILURE: ALL DIURETICS ARE NOT CREATED EQUAL SUZANNE FRAZIER MS, CRNP, NP C, CHFN HEART FAILURE DISEASE MANAGEMENT COORDINATOR PENN STATE HERSHEY MEDICAL CENTER Impact of Heart Failure In

More information

Chronic Venous Insufficiency Compression and Beyond

Chronic Venous Insufficiency Compression and Beyond Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial

More information

Preventing Blood Clots in Adult Patients

Preventing Blood Clots in Adult Patients Manchester Royal Eye Hospital Surgical Services Information for Patients Preventing Blood Clots in Adult Patients This leaflet will give you information on how to reduce the risk of developing blood clots

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Drug Class Review Newer Oral Anticoagulant Drugs

Drug Class Review Newer Oral Anticoagulant Drugs Drug Class Review Newer Oral Anticoagulant Drugs Final Original Report May 2016 The purpose of reports is to make available information regarding the comparative clinical effectiveness and harms of different

More information

Preventing Venous Thromboembolism (VTE)

Preventing Venous Thromboembolism (VTE) INTERNET INFORMATION SOURCES North American Thrombosis Forum www.natfonline.org Clot Care www.clotcare.com MANITOUWADGE GENERAL HOSPITAL National Alliance for Thrombosis/Thrombophilia www.stoptheclot.org

More information

Updates in Anticoagulation for Atrial Fibrillation and Venous Thromboembolism

Updates in Anticoagulation for Atrial Fibrillation and Venous Thromboembolism Disclosures Updates in Anticoagulation for Atrial Fibrillation and Venous Thromboembolism No financial conflicts of interest Member of the ABIM Focused- Practice in Hospital Medicine Self Examination Process

More information

Furosemide: Properties, Alternatives, and the Medication Approval Process. Heather Brown EMS 209-Advanced Pharmacology Don Knox

Furosemide: Properties, Alternatives, and the Medication Approval Process. Heather Brown EMS 209-Advanced Pharmacology Don Knox Furosemide: Properties, Alternatives, and the Medication Approval Process Heather Brown EMS 209-Advanced Pharmacology Don Knox Pre-hospital treatment of critical patients is a key factor in determining

More information

Treatment Options and How They Work

Treatment Options and How They Work Treatment Options and How They Work Robin Offord Director of Clinical Pharmacy UCL Hospitals NHS Foundation Trust robin.offord@uclh.nhs.uk Introducing the term anticoagulant... What they do Inhibit the

More information

Venous Thromboembolism Prophylaxis: Checked!

Venous Thromboembolism Prophylaxis: Checked! Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer

More information

Jordan M. Garrison, MD FACS, FASMBS

Jordan M. Garrison, MD FACS, FASMBS Jordan M. Garrison, MD FACS, FASMBS Peripheral Arterial Disease (PAD) Near or Complete obstruction of > 1 Peripheral Artery Peripheral Venous reflux Disease Varicose Veins Chronic Venous Stasis Ulcer Disease

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Velcro Compression Devices

Velcro Compression Devices Velcro Compression Devices Joseph A. Caprini, MD, MS, FACS, RVT, FACCWS Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical Professor of Surgery University of Chicago

More information

Suspected Deep Vein Thrombosis (DVT) Assessment

Suspected Deep Vein Thrombosis (DVT) Assessment CHI no... First name... DOB... /... /... Last name... Sex: c M c F Address...... Telephone... or attach addressograph label here Hospital/Location: c Hairmyres c Monklands c Wishaw Other (specify)... Ward/Base...

More information

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015 Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015 General Principles: There is compelling data in the medical literature to support

More information

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology

Dr Paul Thibault. Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Dr Paul Thibault Phlebologist & Assistant Editor Phlebology (International Journal) Australasian College of Phlebology Prescribing Effective Compression and PTS Dr Paul Thibault Phlebologist, Newcastle,

More information

Cardiorenal and Renocardiac Syndrome

Cardiorenal and Renocardiac Syndrome And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive

More information

Venous Thromboembolism (VTE)

Venous Thromboembolism (VTE) Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/

More information

Medication Review. Renal Drugs. Pharmacy Technician Training Systems Passassured, LLC

Medication Review. Renal Drugs. Pharmacy Technician Training Systems Passassured, LLC Medication Review Renal Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Renal Drugs PassAssured's Pharmacy Technician Training Program Medication Review Renal Drugs Click

More information

Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center

Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction. Erin H. Murphy, MD Rane Center Complete Evaluation of the Chronic Venous Patient: Recognizing deep venous obstruction Erin H. Murphy, MD Rane Center Disclosure Speaker name: Erin H. Murphy... I have the following potential conflicts

More information

Self Management with Compression

Self Management with Compression Self Management with Compression Joseph A. Caprini, MD, MS, FACS, RVT, FACCWS Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical Professor of Surgery University

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur

More information

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre DVT and Pulmonary Embolus Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre Overview Structure of deep and superficial venous system of upper

More information

Understand. your risk of. blood clot

Understand. your risk of. blood clot Going into hospital? Understand how to reduce your risk of developing a blood clot Printing of this leaflet has been supported by a donation from Bayer HealthCare. Bayer HealthCare has had no editorial

More information

When and How to Use the Newly Approved Oral Anticoagulants to Treat Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Ian del Conde, MD

When and How to Use the Newly Approved Oral Anticoagulants to Treat Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Ian del Conde, MD When and How to Use the Newly Approved Oral Anticoagulants to Treat Acute Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Ian del Conde, MD December 12, 2015 Disclosures CONSULTANT Merck; New Haven

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

Icd 10 swelling rule out dvt

Icd 10 swelling rule out dvt Icd 10 swelling rule out dvt The Borg System is 100 % Icd 10 swelling rule out dvt Deep vein thrombosis (DVT),. In those not highly likely to have DVT, a normal D-dimer result can rule out a diagnosis..

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

Dr. Clark s Frequently Asked Questions

Dr. Clark s Frequently Asked Questions Dr. Clark s Frequently Asked Questions ACTIVITY RESTRICTIONS: Unlike a traditional hip replacement, there are no formal hip precautions after anterior hip replacement. Unless I tell you otherwise, you

More information

Duration anticoagulation VTE. Clinical case WGA april 2017 Dr Borgoens

Duration anticoagulation VTE. Clinical case WGA april 2017 Dr Borgoens Duration anticoagulation VTE Clinical case WGA april 2017 Dr Borgoens Clinical case 70 y old, sedentary computer engineer 1 st episode intermediate high risk pulmonaryembolism(rv dysfunction, positives

More information

Updates in Diagnosis & Management of VTE

Updates in Diagnosis & Management of VTE Updates in Diagnosis & Management of VTE TRACY MINICHIELLO, MD CHIEF, ANTICOAGULATION& THROMBOSIS SERVICE-SAN FRANCISCO VAMC PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Financial Disclosures-NONE

More information

DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES

DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES DEEP VENOUS THROMBOSIS A PRACTICAL APPROACH TO IMPROVING CLINICAL OUTCOMES Jose M. Borromeo M.D. Vascular Surgeon Iowa Heart Center Disclosures: AstraZeneca Pharmaceuticals Cook CVRx LeMaitre Vascular,

More information

Pharmacology I [PHL 313] Diuretics. Dr. Mohammad Nazam Ansari

Pharmacology I [PHL 313] Diuretics. Dr. Mohammad Nazam Ansari Pharmacology I [PHL 313] Diuretics Dr. Mohammad Nazam Ansari Renal Pharmacology Kidneys: Each adult kidney weighs 125-170g in males and 115-155g in females, represent 0.5% of total body weight, but receive

More information

Recurrent varicose veins. Information for patients Sheffield Vascular Institute

Recurrent varicose veins. Information for patients Sheffield Vascular Institute Recurrent varicose veins Information for patients Sheffield Vascular Institute You have been diagnosed as having varicose veins that have recurred (come back). This leaflet explains more about recurrent

More information

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014 HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading

More information

Prevention and treatment of venous thromboembolic disease

Prevention and treatment of venous thromboembolic disease REVIEW Prevention and treatment of venous thromboembolic disease SUSAN McNEILL AND CATHERINE BAGOT Awareness of the risk factors for venous thromboembolic (VTE) disease and timely administration of thromboprophylaxis

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including

More information

When Varicose Veins a Circulatory Problem and how to screen. By Ariel D. Soffer, MD, FACC NCVH MIAMI, 2015

When Varicose Veins a Circulatory Problem and how to screen. By Ariel D. Soffer, MD, FACC NCVH MIAMI, 2015 When Varicose Veins a Circulatory Problem and how to screen. By Ariel D. Soffer, MD, FACC NCVH MIAMI, 2015 Bio-Ariel Soffer, MD, FACC Fellow of the American College of Cardiology since 1998 with post-graduate

More information

DISORDERS OF VENOUS SYSTEM

DISORDERS OF VENOUS SYSTEM DISORDERS OF VENOUS SYSTEM Varicose Veins Any dilated, elongated and tortuous vein irrespective of size Varicose veins are common in the superficial veins of the leg which are subject to high pressure

More information

Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists

Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists Old Drugs for an Old Problem Jay Geoghagan, MD, FACC BHHI Primary Care Symposium February 28, 2014 None. Financial disclosures

More information

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway Anticoagulant Cases 12 11 Intrinsic + Common = aptt 9 8 10 7 4 Extrinsic + Common = PT 5 2 Common Pathway 1 Xa Inhibitors rivaroxaban (Xarelto) apixaban (Eliquis) edoxaban (Savaysa) What is true regarding

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting

More information

Anticoagulation Task Force

Anticoagulation Task Force Anticoagulation Task Force Newest Recommendations Donald Zabriskie, BPharm, MBA, RPh Pharmacy Patient Care Services Cleveland Clinic- Fairview Hospital THE DRUGS THE PERFECT ANTICOAGULANT Oral administration

More information

Updates in Management of Venous Thromboembolic Disease

Updates in Management of Venous Thromboembolic Disease Updates in Management of Venous Thromboembolic Disease November 7 th 2018 UHN Emergency Conference Susan Jenkins RN(EC) NP-Adult Thrombosis and Hemostasis Program University Health Network Disclosures

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

ED Diagnosis of DVT or tools to rule out DVT in your ED

ED Diagnosis of DVT or tools to rule out DVT in your ED ED Diagnosis of DVT or tools to rule out DVT in your ED Ralph Wang UCSF Department of Emergency Medicine 53 yo f c/o left leg swelling recent cholecystectomy its midnight how do you manage this patient?

More information

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types

More information

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy Preventing blood clots while you are in hospital and after you leave Information for patients Pharmacy Why does blood clot? When we cut ourselves, we bleed. To stop us from bleeding too much, chemicals

More information